The Official MicroCap News Source
Watchlist News
Please Login or Register to view News Stories

Hemispherx Biopharma, Inc. - Advanced Specialty Pharmaceutical Company Discusses Clinical Development and Approval in Argentina

SNNLive spoke with Thomas Equels, CEO of Hemispherx Biopharma, Inc. (NYSE American: HEB) at the LD Micro "Main Event" 2017 in Bel Air, CA.

Share With

Wednesday, January 03, 2018

   

© 2018 Stock News Now